Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06545708

Music Perception in SeLECTs

Self-limited epilepsy with centrotemporal spikes (SeLECTS) is the most frequent epilepsy syndrome in children between the ages of 4 and 13 years. SeLECTS is associated in 15 to 30% of patients with specific cognitive deficits, including in particular disorders in language, visuo-spatial memory, declarative memory, and attention. SeLECTS has the potential to evolve into Landau-Kleffner syndrome, the most extreme form of SeLECTS including symptoms of auditory agnosia and aphasia, with potential risks of persistent neuropsychological impairments. In a recent study in adults who had suffered Landau-Kleffner syndrome during childhood, the investigators have shown that these patients, in addition to their known deficit in verbal short-term memory, also exhibit persistent musical difficulties during adulthood, with in particular deficit in melody and rhythm short-term memory.

In the present project, the investigators intend to enlarge the understanding of cognitive deficits generated by SeLECTS in children by investigating the integrity of music perception, both for melody and rhythm. To date, data about music perception in children with epilepsy are scarce and we do not know how distinct components of melody and rhythm perception and memory may be altered.

Recruiting

Interested in participating?

Request Info

Key information

Age range

5 year–14 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Le Vinatier (Bât. 452),, Bron, France

Loading trial locations.

About this study

Self-limited epilepsy with centrotemporal spikes (SeLECTS) is the most frequent epilepsy syndrome in children between the ages of 4 and 13 years. The defining electroclinical feature of SeLECTS is the presence of centrotemporal spikes on EEG between seizures. SeLECTS is associated with specific cognitive deficits in 15 to 30% of patients, including disorders in language, visuo-spatial memory, explicit memory, and attention. The centrotemporal spikes are activated in sleep and, in rare cases, the condition has the potential to evolve into an Epileptic Encephalopathy with spike- and- wave activation in sleep (EE-SWAS), including Landau-Kleffner syndrome. The latest is characterized by symptoms of auditory agnosia and aphasia, with potential risks of persistent neuropsychological impairments. In a previous study, it has been shown that these patients also exhibit persistent musical difficulties.

In the present project, the investigators intend to enlarge the understanding of cognitive deficits generated by SeLECTS in children by analyzing the integrity of music perception, both for melody and rhythm, as well as testing the potential of a musical intervention for auditory and cognitive training in children suffering from SeLECTS.

The current research plan is to explore music perception in this specific epilepsy syndrome, with behavioral testing (Experiment 1) and neuroimaging using functional Near-Infrared Spectroscopy (fNIRS) (Experiment 2), and on the long run, informed by this exploration and previous studies, the design of a musical therapeutic intervention is envisioned in order to evaluate the impact of this program on music perception, language, and memory.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject aged between 5 and 14 years old
  • Non-opposition of parents or guardians for the child's participation in the study
  • No major cognitive impairment and ability to understand and apply instructions
  • Subject affiliated to a social security scheme
  • Subject motivated to participate in the project
  • Proficiency with the French language

For the group of control participants:

  • Without neurological or psychiatric history

For the group of participants with seizure disorder:

  • No neurological (except EPCT) or psychiatric history
  • Diagnosis of self-limited epilepsy with centro-temporal spikes (PTSE) by a qualified healthcare professional.

Exclusion criteria

  • Major cognitive impairment or inability to understand and apply instructions
  • Individuals refusing to participate in the study
  • Pregnant or breastfeeding minors

Treatment and study plan

Patients

Other

This group consists of children and adolescents between the ages of 5 and 14, diagnosed with self-limited epilepsy with centrotemporal spikes by a medical professional (epileptologist or neurologist), and in the active phase of the disorder.

Primary outcomes

  1. Performance obtained in melodic tasks

    Time frame: 2 Years

    Comparison between controls and patients using Bayesian ANOVAs to the percentages of correct responses obtained with melodic tasks

  2. Performance obtained in melodic tasks

    Time frame: 2 Years

    Comparison between controls and patients using Bayesian ANOVAs to response times obtained with melodic tasks;

  3. Performance obtained in rhythmic tasks

    Time frame: 2 Years

    Comparison between controls and patients using Bayesian ANOVAs to the percentages of correct responses obtained with rhythmic tasks

  4. Performance obtained in rhythmic tasks

    Time frame: 2 Years

    Comparison between controls and patients using Bayesian ANOVAs to response times obtained with rhythmic tasks.

Study contacts

Contact information is provided by the study sponsor or research team.

Anne CACLIN, PhD

CONTACT

[email protected]

04.72.13.89.04

Maria PAPADOPOULOU, MD

CONTACT

[email protected]

04 27 85 65 78

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Music and Cognitive Deficits in Self-Limited Epilepsy with Centrotemporal Spikes

Acronym: EpiMUS

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Aug 9, 2024
Registry last updated
Dec 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.